Ownership and insider activity for Cardio Diagnostics Holdings, Inc. (CDIO): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Price
| Price | $2.00 |
| Market Cap | $6M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-06-30 | Fung Peter K | A-Award | 2,854 | $6K |
| 2026-06-30 | Betts Wendy J | A-Award | 2,854 | $6K |
| 2026-06-30 | Intrater James | A-Award | 2,854 | $6K |
| 2026-06-30 | Burton Paul Frederick | A-Award | 2,854 | $6K |
| 2026-03-31 | Fung Peter K | A-Award | 3,205 | $6K |
| 2026-03-31 | Betts Wendy J | A-Award | 3,205 | $6K |
| 2026-03-31 | Intrater James | A-Award | 3,205 | $6K |
| 2026-03-31 | Burton Paul Frederick | A-Award | 3,205 | $6K |
| 2025-12-31 | Fung Peter K | A-Award | 2,306 | $6K |
| 2025-12-31 | Betts Wendy J | A-Award | 2,306 | $6K |
Balance Sheet (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $237087 | $512767 | $4.1M | $1.3M | $7.8M | $5.1M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | $901 | 0 | $4960 | $18612 | $8126 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $245917 | $803507 | $5.9M | $2.8M | $8.8M | $5.9M |
| Property, Plant & Equipment | 0 | 0 | 0 | $1.1M | $1.1M | $959680 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $200458 | $298487 | $358641 | $536735 | $706422 | $873182 |
| Total Assets | $446375 | $1.1M | $6.2M | $4.5M | $10.6M | $7.8M |
| Accounts Payable | $39539 | $33885 | $1.1M | $243213 | $87661 | $97442 |
| Short-term Debt | 0 | 0 | $849032 | $374000 | $306764 | $269790 |
| Total Current Liabilities | $386010 | $33885 | $1.9M | $841142 | $631695 | $604839 |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $386010 | $33885 | $1.9M | $1.5M | $1.1M | $793061 |
| Retained Earnings | -$710113 | -$1.3M | -$6.0M | -$14.4M | -$22.8M | -$29.2M |
| Total Equity | $60365 | $1.1M | $4.3M | $3.0M | $9.6M | $7.0M |
| Total Debt | 0 | 0 | $849032 | $1.3M | $969863 | $695619 |
| Net Debt | -$237087 | -$512767 | -$3.3M | -$22495 | -$6.9M | -$4.4M |
| Working Capital | -$140093 | $769622 | $3.9M | $1.9M | $8.2M | $5.3M |
Financial Health
| Debt / Equity | 0.05 |
| Current Ratio | 17.15 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -3.61 |
Profitability
| Return on Equity | -93.19% |
| Return on Invested Capital | -84.55% |
| Return on Assets | -83.67% |
| Gross Margin | -555.03% |
| Operating Margin | -44690.68% |
| Net Margin | -44771.83% |
Related companies: ADIL · ADXN · BCDA · BCLI · CELZ · IBO · MTNB
Explore sector: Healthcare · Biotechnology
More sections of CDIO: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks